计算机科学
管道(软件)
任务(项目管理)
变压器
命名实体识别
生物医学文本挖掘
人工神经网络
人工智能
过程(计算)
药品
机器学习
数据挖掘
文本挖掘
工程类
医学
系统工程
电压
精神科
电气工程
程序设计语言
操作系统
作者
Dimitrios Zaikis,Ioannis Vlahavas
标识
DOI:10.1016/j.artmed.2021.102153
摘要
Drug-Drug Interaction (DDI) extraction is the task of identifying drug entities and the potential interactions between drug pairs from biomedical literature. Computer-aided extraction of DDIs is vital for drug discovery, as this process remains extremely expensive and time consuming. Therefore, Machine Learning-based approaches can reduce the laborious task during the drug development cycle. Numerous traditional and Neural Network-based approaches for Drug Named Entity Recognition (DNER) and the classification of DDIs have been proposed over the years. However, despite the development of many effective methods, achieving good prediction accuracy is an area where significant improvement can be made. In this article, we present a novel end-to-end approach that tackles the overall DDI extraction task as a pipelined method via the Transformer model architecture and biomedical domain pre-trained weights. In our approach, the tasks of DNER and DDI classification are executed successively to extract the drug entities and to classify their relationship respectively. The proposed approach, TP-DDI, integrates prior knowledge by using pre-trained weights from BioBERT and improves in both the Drug Named Entity Recognition and the overall DDI extraction task over the current state-of-the-art approaches on the DDI Extraction 2013 corpus.
科研通智能强力驱动
Strongly Powered by AbleSci AI